BUSINESS: Certus Critical care was awarded two Department of Defense grants for the development of an endovascular device

dWeb.News Article from Daniel Webster dWeb.News

dWeb.News Article from Daniel Webster dWeb.News

BUSINESS: By Daniel Webster, dWeb.News Publisher

.

Salt Lake City, UT — (ReleaseWire) — 10/12/2021 —Certus Critical Care Inc, a medical device company developing AI-enabled endo-aortic catheters for the treatment of stroke, catastrophic hemorrhage and cardiac arrest has just been awarded two grants from the Department of Defense (DOD) totaling $3.1 million. The non-dilutive equity grant of $1.2 million was the first. This will allow Certus to continue developing its Endovascular Variable Aortic Catheter. EVAC, a next-generation endovascular device that provides automated functionality for precise blood pressure control, is the first of two grants. Hemorrhagic shock will be the FDA’s first indication. The EVAC System consists both of an automated controller and an endovascular catheter. The catheter is an endovascular device with a low profile that uses precision sensors to save patients who have suffered from profound blood loss ..

Plans for additional blood pressure control in cardiac arrest and acute stroke settings are being developed. The EVAC system will not only be a great tool for warfighters in difficult environments, but it will also make it possible to stabilize critically injured patients in well-resourced civilian trauma centres.

Certus also received a $1.9million grant from the DOD to continue developing their advanced ventilator analytics monitor. The Vent Right Monitor (VRM), a next-generation inline device, monitors, analyzes, and provides clinical decision support to patients who are receiving invasive mechanical ventilation in an ICU, ED, or prehospital setting. The VRM’s advanced ventilator/patient asynchrony detection software will reduce the risk of patients being in contact with mechanical ventilators. This will result in fewer ICU days and fewer patient complications.

Dr. Austin Johnson, Certus President and founder, stated that “these two grants will continue fuel the rapid development these life-saving technology.” We are excited about this significant vote of confidence from the Department of Defense. But we also feel motivated by the need for precision medical technology to treat the patients we see every day. “

About Certus Critical Care, Inc

Certus Critical Care, Inc, is a physician/scientist-led, veteran-owned, Salt Lake City-based medical device company that is tackling some of the most challenging aspects of modern critical care. Certus has deep insight into the interaction of advanced robotics with human physiology and is leading the way in precision hemodynamic management and critical care. Certus is currently developing catheter-based hemodynamic optimization technology to address the unmet clinical needs for patients with ischemic stroke, catastrophic bleeding, cardiac arrest, and other conditions. For more information, log on to https://www.certuscriticalcare.com/

Read More

For more dWeb.News business news: https://dweb.news/news-sections/business-news/

The post BUSINESS: Certus Critical care was awarded two Department of Defense grants for the development of an endovascular device appeared first on dWeb.News dWeb.News from Daniel Webster Publisher dWeb.News – dWeb Local Tech News and Business News

The post BUSINESS: Certus Critical care was awarded two Department of Defense grants for the development of an endovascular device appeared first on dWeb.News dWeb.News from Daniel Webster Publisher dWeb.News – dWeb Local Tech News and Business News

dWeb.NewsRead More

Similar Posts